Jim Cramer on Vertex Pharmaceuticals: “I Wish I Had Bought It for the Charitable Trust a Long Time Ago”

I deliberation Vertex is precise strong. I privation I had bought it for the Charitable Trust a agelong clip ago, erstwhile we had the CEO on. It was an fantabulous call, and past I got acold feet. That was a mistake. It’s a bully buy.

Stock marketplace data. Photo by Burak The Weekender connected Pexels

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) develops and commercializes transformative medicines for superior conditions, including cystic fibrosis, sickle compartment disease, and acute pain. Hardman Johnston Global Equity Strategy stated the pursuing regarding Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) successful its 4th fourth 2025 capitalist letter:

During the 4th we liquidated Corteva Inc., T-Mobile US, Inc. and Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX). After meetings with FDA, Vertex Pharmaceuticals Inc. does not spot a way guardant for a wide neuropathic chronic symptom statement for Journavx. This lowered imaginable TAM of Journavx successful chronic pain. VX-993 (next procreation NaV 1.8) signifier II information failed to amusement competitive/significant benefits truthful VRTX volition not prosecute this arsenic a monotherapy. Journavx is launching good successful acute symptom but inactive aboriginal days truthful banal reacted negatively to chronic symptom updates. Outside of pain, each pipeline updates were affirmative crossed kidney and diabetes nevertheless fixed the slower ramp of symptom we thought determination were amended opportunities elsewhere successful the portfolio and picked Elanco implicit Vertex.

While we admit the imaginable of VRTX arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double successful 3 Years and 15 Stocks That Will Make You Rich successful 10 Years 

Disclosure: None. Follow Insider Monkey connected Google News.